ClinicalTrials.Veeva

Menu

Effect of Hyponatremia in Small Cell Lung Cancer

A

Ankara City Hospital

Status

Completed

Conditions

Small Cell Lung Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT04451460
AnkaraSanatoryum

Details and patient eligibility

About

In this retrospective study, the investigators determined the frequency of hyponatremia in small cell lung cancer and the prognosis. 126 (27%) of 466 patients were hyponatremic. Hyponatremia could not be corrected in 50.8% (n=64) of hyponatremic patients. Survival was found to be better in the group of whom hyponatremia was corrected.

Enrollment

466 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients diagnosed with SCLC between January 2012 and January 2017 in our hospital were retrospectively screened

Exclusion criteria

Over 18 age If data doesn't exist

Trial design

466 participants in 2 patient groups

Hyponatremia
Description:
Hyponatremic small cell cancer patients
Normonatremia
Description:
Normonatremic small cell cancer patients

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems